Načítá se...
Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results
This report presents our experience with T therapy in a cohort of T-deficient men on active surveillance (AS) for Gleason 3 + 3 and Gleason 3 + 4 prostate cancer (PCa). A retrospective chart review identified 28 men with T deficiency who underwent T therapy (T group) for at least 6 months while on A...
Uloženo v:
| Vydáno v: | Asian J Androl |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4736350/ https://ncbi.nlm.nih.gov/pubmed/26306850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.160270 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|